J
Jerzy Sadowski
Researcher at Jagiellonian University Medical College
Publications - 286
Citations - 9986
Jerzy Sadowski is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Aortic valve replacement & Aortic valve. The author has an hindex of 31, co-authored 280 publications receiving 9235 citations. Previous affiliations of Jerzy Sadowski include University of Maryland, Baltimore & University of Oxford.
Papers
More filters
Journal Article
Invasive electrophysiology Thoracoscopic Ex-Maze III procedure and radiofrequency catheter ablation – a hybrid therapy for permanent atrial fibrillation. A case report
TL;DR: It is proposed that the hybrid therapy including thoracoscopic maze procedure and catheter RF ablation of flutter isthmus might be effective in some patients with permanent AF.
Journal Article
Architecture of intra-atrial thrombi in patients with severe mitral stenosis.
Journal Article
Levels of troponin I, tropoinin T, isoenzyme MB creatine kinase and myoglobins in blood serum for perioperative diagnosis of myocardial infarction in patients after coronary artery bypass graft surgery with extracorporeal circulation
Janusz Andres,Ewa Stępień,M. Szajna-Zych,Rafał Drwiła,M. Zietkiewicz,Jerzy Sadowski,Bogusław Kapelak,A. Dziatkowiak +7 more
TL;DR: All markers studied are reliable biochemical tests for perioperative myocardial infarction, however, the analysis of ROC curves suggested that cTnI and cTtnT might be more useful for diagnosis of perioperitoneal infarctions after conventional coronary artery bypass surgery.
Journal ArticleDOI
Current approach to transfemoral aortic valve replacement.
Paweł Kleczyński,Danuta Sorysz,Łukasz Rzeszutko,Jarosław Trębacz,Marek Tomala,Robert Sobczyński,Maciej Bagienski,Beata Bobrowska,Jerzy Sadowski,Dariusz Dudek +9 more
TL;DR: A 73 year-old male with severe aortic stenosis and high perioperative risk who was considered as candidate for percutaneous valve treatment underwent successful transfemoral aortIC valve replacement with 29 mm device in analgosedation.
Journal ArticleDOI
Five-year Outcomes of Aortic Valve Replacement Using a Bioprosthetic Valve with the Novel RESILIA Tissue: Final Study Results
Krysztof Bartus,Agata Bilewska,Maciej Bochenek,Maciej Stapor,Radosław Litwinowicz,Jacek Różański,Jerzy Sadowski,Bogusław Kapelak,Mariusz Kusmierczyk +8 more
TL;DR: Increased life expectancy highlights the need for extended longevity of bioprosthetic tissue in aortic valve replacement (AVR) and the outcomes through 5 year follow up are reported.